CSL Ltd (CSL)

Sydney
Currency in AUD
Disclaimer
252.04
-3.56
(-1.39%)
Closed
Trading near 52-week Low
Day's Range
247.61
255.60
52 wk Range
247.61
314.28
Volume
1,253,406
Bid/Ask
252.04 / 252.07
Prev. Close
255.6
Open
255.6
Day's Range
247.61-255.6
52 wk Range
247.61-314.28
Volume
1,253,406
Average Volume (3m)
858,863
1-Year Change
-12.17%
Shares Outstanding
483,064,837
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
210.18
Downside -16.61%

People Also Watch

111.050
RIO
+0.14%
22.990
RMD
+4.79%
35.670
WDS
-1.05%
37.590
WOW
+0.05%
How do you feel today about CSL?
Vote to see community's results!
or

CSL Ltd Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Employees
32065
Market
Australia

Income Statement